Eczacıbaşı Yatırım Holding was founded in Istanbul in 1973 and the announcement regarding its establishment was made in the Turkish Trade Registry Gazette dated 29.12.1973 and numbered 17-5037.
The main scope of activity of Eczacıbaşı Yatırım Holding is to participate in the capitals of existing or future equity companies with a profit making capability or potential, established in such areas as may be deemed appropriate by it, or to invest in shares and other securities issued or to be issued by such companies.
They are traded on Borsa Istanbul (BIST).
18.43% of Eczacıbaşı Yatırım Holding's shares are free floating shares.
Please click here to find out about the shareholding structure of Eczacıbaşı Yatırım Holding.
Subsidiaries of Eczacıbaşı Yatırım Holding;
Trade Name | Share Ratio (%) |
---|---|
İntema İnşaat ve Tesisat Malzemeleri Yatırım ve Pazarlama A.Ş. | 46,21 |
EİS Eczacıbaşı İlaç. Sınai ve Finansal Yatırımlar San. ve Tic. A.Ş. | 30,62 |
Eczacıbaşı Holding A.Ş. | 11,54 |
İntema İnşaat ve Tesisat Malzemeleri Yatırım ve Pazarlama A.Ş. (INTEM)
EİS Eczacıbaşı İlaç, Sınai ve Finansal Yatırımlar San. Ve Tic. A.Ş. (ECILC)
Please click here to find out about the Articles of Association.
The issued capital of Eczacıbaşı Yatırım Holding is TRY 105,000,000.
The number of shares representing the issued capital is 105,000,000. There is no privileged share, and each share has one voting right.
Please click here to find out about the capital increase and dividend distribution details of Eczacıbaşı Yatırım Holding.
The Board of Directors of Eczacıbaşı Yatırım Holding consists of six members, two of whom are independent. Please click here to find out details regarding the Members of the Board of Directors.
The fiscal year of Eczacıbaşı Yatırım Holding covers the January-December period of a 12-month calendar year.
Eczacıbaşı Yatırım Holding discloses its financial results 4 times a year for 3, 6, 9 and 12 months in accordance with the regulations of the Capital Markets Board (CMB). Please click here to find out about the financial statements announced.
Details of the General Assembly are disclosed on the Public Disclosure Platform and on the Company's website at least 3 weeks prior to the meeting date. Please click here to find out details of the General Assembly meetings.
Please click here to find out about the dividend distribution policy of Eczacıbaşı Yatırım Holding.
The independent audity company of Eczacıbaşı Yatırım Holding is “PwC Bağımsız Denetim ve Serbest Muhasebeci Mali Müşavirlik Anonim Şirketi”.
Please click here to find out the activity reports of Eczacıbaşı Yatırım Holding.
Please click here to find out the Work Ethics of Eczacıbaşı Yatırım Holding.
Please click here to find out the contact details of Investor Relations Department of Eczacıbaşı Yatırım Holding.
Please click here for more information on Eczacıbaşı Group.